Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 143,251 | 136,708 | 89,789 | 185,636 | 241,148 |
| Marketable Securities | 117,055 | 67,107 | 7,907 | 499 | 27,091 |
| Receivables | 21,235 | 21,469 | 15,268 | 29,629 | 15,874 |
| Inventories | N/A | N/A | N/A | N/A | 1,606 |
| Other current assets | 5,528 | 7,721 | 30,847 | 9,665 | 29,643 |
| TOTAL | $287,069 | $233,005 | $143,811 | $225,429 | $315,362 |
| Non-Current Assets | |||||
| PPE Net | 45,895 | 54,681 | 63,621 | 78,846 | 71,673 |
| Investments And Advances | 7,521 | 7,853 | 0 | 0 | 0 |
| Intangibles | 1,116 | 671 | 718 | 1,854 | 1,584 |
| Other Non-Current Assets | 41,944 | 38,060 | 53,066 | 75,947 | 80,852 |
| TOTAL | $96,476 | $101,265 | $117,405 | $156,647 | $154,109 |
| Total Assets | $383,544 | $334,270 | $261,216 | $382,076 | $469,471 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,134 | 5,289 | 5,088 | 2,354 | N/A |
| Accounts payable and accrued liabilities | 18,664 | 19,069 | 21,456 | 23,762 | 24,609 |
| Other current liabilities | 10,925 | 11,959 | 13,656 | 14,602 | 20,258 |
| TOTAL | $166,269 | $155,144 | $62,995 | $49,348 | $52,015 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,882 | 49,125 | 20,531 | 20,030 | 28,836 |
| Deferred Revenues | 112,161 | 110,325 | 59 | 301 | 452 |
| Other Non-Current Liabilities | 35,360 | 52,532 | 59,642 | 87,135 | 96,183 |
| TOTAL | $86,242 | $94,431 | $72,279 | $96,255 | $108,610 |
| Total Liabilities | $252,511 | $249,575 | $135,275 | $145,602 | $160,625 |
| Shareholders' Equity | |||||
| Common Shares | 5,889 | 4,365 | 2,955 | 2,945 | 2,785 |
| Retained earnings | -329,607 | -405,766 | -439,504 | -698,326 | -587,035 |
| Other shareholders' equity | -39,537 | -36,689 | -20,632 | -2,841 | 20,962 |
| TOTAL | $131,033 | $84,695 | $125,941 | $236,474 | $308,846 |
| Total Liabilities And Equity | $383,544 | $334,270 | $261,216 | $382,076 | $469,471 |